Sinopharm Tech Holdings Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was HKD 40.99 million compared to HKD 77.81 million a year ago. Net loss was HKD 88 million compared to HKD 106.34 million a year ago.

Basic loss per share from continuing operations was HKD 0.49 compared to HKD 0.6175 a year ago.